Context Patients with periampullary adenocarcinomas undergo the same resectional
surgery as that of patients with pancreatic ductal adenocarcinoma. Although adjuvant …

There are different cancers in the peri-ampullary region, including pancreatic ductal
adenocarcinoma (PDAC), duodenum cancers (DCs), and ampullary adenocarcinoma …

Background Periampullary cancers are uncommon malignancies, often amenable to
surgery. Several studies have suggested a role for adjuvant chemotherapy and …

Ampullary cancer is a rare periampullary cancer currently with no targeted therapeutic
agent. It is important to develop a deeper understanding of the carcinogenesis of ampullary …

Introduction Ampullary adenocarcinoma is a rare entity with limited data on prognostic
factors. The aim of this study is to identify prognostic factors and assess the benefit of …

Aims This study is to examine the significance of the number and ratio of positive nodes in
post‐neoadjuvant therapy pancreaticoduodenectomy (PD) for pancreatic ductal …

Background Ampullary adenocarcinoma is considered to have a better prognosis than either
pancreatic or bile duct adenocarcinoma. Pancreaticoduodenectomy is associated with …

Background Current nodal staging (N-staging) of ampullary carcinoma in the TNM staging
system distinguishes between node-negative (N0) and node-positive (N1) disease but does …

Objective The prognosis of ampullary adenocarcinoma (AA) usually is favorable; however, a
subset of AA have poor biology and outcomes similar to pancreatic cancer. Patients in this …

Background Ampullary carcinoma (AC) is a relatively rare entity often managed as a
biliopancreatic carcinoma. AC has a better prognosis than peri ampullary tumors after …